Drugs for Premature Ejaculation: Most Men Soon Quit Them

Solutions that are drug-free, entail minimal adverse effects, and permit spontaneity during intercourse are on the horizon.

• Topical gels can numb nerves and delay ejaculation temporarily.
• Oral pills like dapoxetine are prescription medications for PE.
• Herbal supplements claim to improve stamina and control.
• SSRIs often prescribed off-label to help delay climax.
• Some lifestyle changes, like stress reduction, may improve symptoms.

However, additional clinical studies would be beneficial in confirming the effectiveness of these therapies, potentially establishing them as possible alternatives to pharmacological PE treatments. This is a review article with no original scientific data. Althof S. Prevalence, characteristics and implications of premature ejaculation/rapid ejaculation.

How well do pills work against ejaculation too fast?

The sole distinction between the groups was the inclusion of the Myhixel © device. The primary metric was the men enhancement pills “fold increase” in IELT. At the conclusion of the 8-week treatment, the geometric means of IELT demonstrated more favorable outcomes for the device group, albeit without statistical significance (P = 0.11) (an increase of 30 s versus 90 s from baseline in the exercise-only and device groups, respectively). Notably, in the device group, the fold increase in IELT was significantly higher compared to the exercise-only group, at 4.27 versus 2.09, respectively (P = 0.001) [53] (See Table 1 for comparison between the new technologies). While there are treatments for PE that are actually, clinically proven, scientifically significant and FDA cleared (i.e behavioral therapies, topical anesthetics, and certain medications and medical devices), there are also numerous devices and products on the market that claim to treat or prevent PE but lack scientific evidence to support their efficacy (i.e Morari device- #how-it-works, Vaacum constriction devices, male vibrators).

RedBox Rx Reviews

It’s crucial to approach any device claiming to treat PE with skepticism and caution unless there is robust scientific evidence supporting its efficacy and safety. Currently, the standards of care in PE treatment are mainly SSRIs and topical anesthetics. However, the available drug treatments for PE come with limited effectiveness, a range of adverse effects, and a high rate of discontinuation. A definitive cure for PE, or at least therapies allowing for spontaneity during intercourse, remain elusive. Encouragingly, data from studies utilizing newly developed technological techniques and medical devices in PE treatment show promise. Diagnostic and statistical manual of mental disorders: DSM-5.

An evidence-based unified definition of lifelong and acquired premature ejaculation: report of the second International Society for Sexual Medicine AdHoc Committee for the definition of premature ejaculation.

Rights and permissions

Future comparative studies are imperative to ascertain whether on-demand TENS treatment methods can match or surpass the efficacy of pharmacological agents in delaying ejaculation for patients with PE. The concept of utilizing electrical stimulation to prolong ejaculation latency time gained support from Cizmezi et al. In this controlled study, high-frequency burst and continuous low-frequency (LF) neuromuscular electrical stimulation was applied to the rats for 30 min (n = 8 for each group including control). They found a significant difference between the groups in terms of ejaculation time (1344.71 ± 105.9, p = 0.002). Other measured PE parameters did not differ significantly between the groups (change in basal seminal vesicle pressure, seminal vesicle maximum pressure, number and interval time of seminal vesicle contractions and bulbospongiosus muscle EMG activities).

4. The stop-start method

They concluded that continues low-frequency neuromuscular electrical stimulation (2 Hz and 200 µs transition time) significantly prolonged the ejaculation time in rats. This study strengthens the theoretical mode of action by maintaining sub-tetanic continuous contraction that prevents the rhythmic contractions necessary for completing the ejaculatory process [46]. TPTNS therapy has found extensive application in pelvic floor physiotherapy [47]. The underlying principle of electrostimulation therapy is rooted in the intricate sensorimotor function of the posterior tibial nerve, originating from T4–S3 roots. While the emission phase of ejaculation is primarily governed by stimuli from the T12–L1 area [48], the expulsion phase is predominantly regulated at the S2–S4 level [49, 50]. Prevalence and correlates of premature ejaculation in a primary care setting: a preliminary cross-sectional study.

Premature ejaculation and erectile dysfunction prevalence and attitudes in the Asia-Pacific region.

Prevalence of the complaint of ejaculating prematurely and the four premature ejaculation syndromes: results from the Turkish Society of Andrology Sexual Health Survey.

Warning: Watch out for unreliable pills

This study revealed an improvement in IELT scores in the Sham group, even though no electrical current was applied. This suggests that the contact of the TPTNS probe with the body may have induced a placebo effect. There were no statistically significant differences observed between patients treated with TPTNS or Sham in terms of the percentage change in IELT scores from pre-to-post-procedure (0.38 ± 0.47 vs. 0.23 ± 0.67, P = 0.415). However, it’s important to note that a major limitation of this study was the absence of randomization, potentially introducing bias in participant selection.

The pause-squeeze technique

The initial outcomes of TPTNS in treating PE appear conflicting, highlighting the need for randomized controlled studies involving large patient cohorts. In recent years, a new approach to treating PE has emerged, involving the use of a masturbation aid device in conjunction with behavioral techniques. In a multicenter randomized clinical trial utilizing a parallel group design to assess the effectiveness of the electronic masturbation device known as Myhixel © (MYHIXEL, Seville, Spain) in PE treatment, Rodriguez et al. assigned 52 patients to two treatment groups, with only 40 completing the study. All patients underwent an 8-week Sphincter Control Training program. An update of the International Society of Sexual Medicine’s Guidelines for the diagnosis and treatment of premature ejaculation (PE). Waldinger MD, Quinn P, Dilleen M, Mundayat R, Schweitzer DH, Boolell M. A multinational population survey of intravaginal ejaculation latency time.

• Herbal pills often boast fewer side effects than pharmaceuticals.
• Supplements marketed for delay are often unregulated.
• Proper diagnosis ensures the right treatment approach.
• Pills should not be used as the sole solution; therapy is beneficial.
• Consistency in medication can improve long-term control.

A five-nation survey to assess the distribution of the intravaginal ejaculatory latency time among the general male population. Characteristics of men who are bothered by rapid ejaculation: results from clinical intake surveys.

• Pills that increase serotonin tend to have longer-lasting effects.
• Men should discuss all medications with their healthcare provider.
• The placebo effect can sometimes influence perceived improvements.
• Overuse of delay pills may lead to decreased natural ability.
• PE pills are one part of a holistic approach including therapy and lifestyle.

Advances in understanding and treating premature ejaculation. Frequency of etiological factors among patients with acquired premature ejaculation: prospective, observational, single-center study. Significance of penile hypersensitivity in premature ejaculation.

Corona G, Rastrelli G, Limoncin E, Sforza A, Jannini EA, Maggi M.

• Dapoxetine is a fast-acting medication approved for PE.
• Combining medications with therapy enhances results.
• Some pills contain PDE5 inhibitors, like sildenafil, for better control.
• Side effects of pills may include dizziness or nausea.
• Always check for drug interactions before taking PE pills.

Interplay between premature ejaculation and erectile dysfunction: a systematic review and meta-analysis. Association between lifelong premature ejaculation and polymorphism of tryptophan hydroxylase 2 gene in the Han population.

Beyond Pills: Holistic and Behavioral PE Treatments

Consequently, TPTNS has the potential to inhibit both the emission (through the sympathetic system) and expulsion (through the parasympathetic–somatic ejaculation system) phases of ejaculation. In a phase II trial, TPTNS was assessed as a novel treatment approach for PE. Eleven patients with PE underwent TPTNS sessions lasting 30 min, three times a week for 12 weeks. In total, 6 out of 11 (54%) patients who completed the 12-week treatment period exhibited a three-fold increase in IELT compared to baseline (P = 0.037). Only two patients reported complications, such as constipation (n = 1) and a sensation of heat in the leg (n = 1).

Premature ejaculation (PE), or now, as it is often referred, rapid ejaculation (RE), is a common medical condition that is tough to define and affects up to 30 percent of men.

Importantly, no reported adverse effects led to a change in therapy adherence. However, it is important to note that this study has significant limitations, including a very low number of participants, the absence of a control group, and a lack of randomization [51]. In a trial conducted in 2020, the effectiveness of TPTNS treatment was compared to sham therapy in a group of 60 men with PE. They underwent 30-min sessions of either TPTNS or buy cenforce 120mg sham therapy once a week. At the conclusion of the 12-week treatment period, the average IELT values increased from 40.4 s to 51.25 s for patients receiving TPTNS, while for those treated with sham therapy, the values went from 37.9 s to 42.5 s (P = 0.030) [52]. The 5-HT2C receptor gene Cys23Ser polymorphism influences the intravaginal ejaculation latency time in Dutch Caucasian men with lifelong premature ejaculation.

Sexual techniques

The mean ratio of fold change (Active/Sham) was 1.4, significantly different from 1.0 (P = 0.02). In a subgroup analysis of subjects exhibiting improvement in IELT, 91% (31/34) of individuals in the Active Group demonstrated enhanced IELT during the treatment period compared to baseline. Responders exhibited a mean time-fold increase in IELT of 2.04, with a 95% confidence interval ranging from 1.68 to 2.40. No instances of serious or severe treatment-emergent adverse events (AEs) were reported. Two minor AEs occurred in the Active Group (2/186 sessions), both attributed to the study device.

2. Condoms

One participant reported “Discomfort due to device vibration in the inguinal scar site,” while another reported “Pain and discomfort during sexual intercourse in the pelvic area”; nonetheless, both individuals continued their participation in the study. Consequently, the AE rate was 1.1% in the Active Group, contrasting with 0.0% (0/70) in the Sham Group (P = 1.00). This study introduces an innovative approach to addressing lifelong PE by extending on-demand coital duration through electric stimulation of the ejaculation muscles using the In2 patch. This method shows promise as a potential on-demand, non-invasive, and drug-free treatment for PE. However, it is essential to acknowledge the study’s limitations, including a restricted participant pool, exclusion of individuals with acquired PE, short-term follow-up, a focus solely on vaginal penetration, omission of men engaged in anal penetration, exclusion of couples with shorter-term relations, and utilization of a device based on a theoretical mechanism of action.